<?xml version="1.0" encoding="UTF-8"?>
<p>Thrombocytopenia is common in dengue fever, but transient and spontaneous recovery in platelet counts is usually observed [
 <xref rid="pone.0219287.ref028" ref-type="bibr">28</xref>, 
 <xref rid="pone.0219287.ref036" ref-type="bibr">36</xref>, 
 <xref rid="pone.0219287.ref037" ref-type="bibr">37</xref>]. However, bleeding is a dreaded clinical manifestation of dengue fever. Thus, for years, prophylactic platelet transfusion has been performed in many cases in an attempt to reduce this risk. In recent years, several studies have demonstrated the importance of not using prophylactic blood components, especially platelets [
 <xref rid="pone.0219287.ref007" ref-type="bibr">7</xref>, 
 <xref rid="pone.0219287.ref024" ref-type="bibr">24</xref>, 
 <xref rid="pone.0219287.ref028" ref-type="bibr">28</xref>, 
 <xref rid="pone.0219287.ref034" ref-type="bibr">34</xref>â€“
 <xref rid="pone.0219287.ref036" ref-type="bibr">36</xref>, 
 <xref rid="pone.0219287.ref038" ref-type="bibr">38</xref>] because they were not superior to supportive care in preventing bleeding and had a higher incidence of side effects [
 <xref rid="pone.0219287.ref011" ref-type="bibr">11</xref>, 
 <xref rid="pone.0219287.ref024" ref-type="bibr">24</xref>, 
 <xref rid="pone.0219287.ref037" ref-type="bibr">37</xref>, 
 <xref rid="pone.0219287.ref039" ref-type="bibr">39</xref>].
</p>
